Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Biotechnology company Moderna (NASDAQ:MRNA) in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other ...

Laura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial College London.

We did not, however, imagine that over the intervening months, vaccination in general, and mRNA vaccines in particular, would escalate into a political wedge issue that threatens to undermine the ...

The mRNA-based SARS-CoV-2 vaccines are believed to impart protection ... Avidity ELISAs were performed on sample dilutions with optical densities (OD) between 0.50 to 1.30 OD units at 450nM; 1.00 was ...

Oracle Chairman Larry Ellison highlighted the potential medical benefits of the investment, stating that AI could be used to detect cancers and customize mRNA vaccines to treat them within 48 hours.

Currently, mRNA vaccines require expensive and challenging ... over more traditional ways of administering vaccines. For example, the dried form of the vaccine is more stable at higher ...

You can make that vaccine, that mRNA vaccine, you can make that robotically, again using AI, in about 48 hours." In the early hours as president, Trump nullified Biden-era executive orders ...